109
Views
6
CrossRef citations to date
0
Altmetric
Review

Impact and treatment of anemia in the elderly: clinical, epidemiological and economic perspectives

, &
Pages 577-590 | Published online: 09 Jan 2014

References

  • World Health Organization. Nutritional Anemias: Report Of A WHO Scientific Group. Technical Report Series No. 405. World Health Organization, Geneva, Switzerland (1968).
  • Guralnik J, Eisenstaedt R, Ferrucci L, Klein H, Woodman R. Prevalence of anemia in persons 65 years and older in the United States: evidence of a high rate of unexplained anemia. Blood104, 2263–2286 (2004).
  • National Kidney Foundation Practice. Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification139, 137–147 (2003).
  • Smith D. Anemia in the elderly. Am. Fam. Physician62, 1565–1572 (2000).
  • Penninx B, Guralnik J, Onder G, Ferucci L, Wallace R, Pahor M. Anemia and decline in physical performance among older persons. Am. J. Med.115(2), 104–110 (2003).
  • Berghe C, Wilson A, Ershler W. Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am. J. Med.116(7A), S3–S10 (2004).
  • Joosten E, Pelemans W, Hiele M et al. Prevalence and causes of anaemia in a geriatric hospitalized population. Gerontology38, 111–117 (1992).
  • Woodman R, Ferrucci L, Guralnik J. Anemia in older adults. Curr. Opin. Hematol.12(2), 123–128 (2005).
  • Carmel R. Anemia and aging: an overview of clinical diagnostic and biological issues. Blood Rev.15, 9–18 (2001).
  • Artz A, Fergusson D, Drinka P et al. Prevalence of anemia in skilled-nursing home residents. Arch. Gerontol. Geriatr.39(3), 201–206 (2004).
  • Artz A, Fergusson D, Drinka P et al. Mechanisms of unexplained anemia in the nursing home. J. Am. Geriatr. Soc.52(3), 423–427 (2004).
  • Choi C, Lee J, Park K et al. Incidence of anemia in older Koreans: community-based cohort study. Arch. Gerontol. Geriatr.41(3), 303–339 (2005).
  • Ania B, Suman V, Fairbanks V et al. Incidence of anemia in older people: an epidemiologic study in a well defined population. J. Am. Geriatr. Soc.45, 825–831 (1997).
  • Chaves P, Mody S, Siegartel L, Hill K, Woodman R. Epidemiology of anemia in older adults. Presented at: American Society of Consultant Pharmacists (ASCP) 35th Annual Meeting and Exhibition, San Francisco, CA, USA, 3–6 November (2004).
  • Chaves P, Mody S, Siegartel L, Yektashenas B, Woodman R. Occurrence and clinical characteristics of unrecognized anemia in older adults. Presented at: American Society of Consultant Pharmacists (ASCP) 35th Annual Meeting and Exhibition, San Francisco, CA, USA, 3–6 November (2004).
  • Aapro M, Cella D, Zagari M. Age, anemia and fatigue. Semin. Oncol.3(Suppl. 8), 55–59 (2002).
  • Lipschitz D. Medical and functional consequences of anemia in the elderly. J. Am. Geriatr. Soc.51(Suppl. 3), S10–S13 (2003).
  • Gabrilove J, Cleeland C, Livingston R et al. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times weekly dosing. J. Clin. Oncol.19, 2875–2882 (2001).
  • Littlewood T, Bajetta E, Nortier J et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J. Clin. Oncol.19(11), 2865–2874 (2001).
  • Witzig T, Silberstein P, Loprinzi C et al. Phase III, randomized, double-blind study of epoetin alfa versus placebo in anemic patients with cancer undergoing chemotherapy. J. Clin. Oncol.23(12), 2606–2617 (2005).
  • Balducci L, Hardy C, Lyman G. Hematopoiesis and aging. In: Biological Basis of Geriatric Oncology. Balducci L, Extermann M (Eds). Springer, NY, USA, 111–134 (2005).
  • Kamenetz Y, Beloosesky Y, Zeltzer C et al. Relationship between routine hematological parameters and, serum IL-3, IL-6 and erythropoietin and mild anemia and degree of function in the elderly. Aging (Milano)10, 32–38 (1998).
  • Penninx B, Pahor M, Cesari M et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J. Am. Geriatr. Soc.52(5), 719–724 (2004).
  • Ershler W, Keller E. Age associated increased interleukin-6 gene expression, late-life diseases and frailty. Annu. Rev. Med.51, 245–270 (2000).
  • Balducci L. Epidemiology of anemia in the elderly: information on diagnostic evaluation. J. Am. Geriatr. Soc.51(Suppl.), 2–9 (2003).
  • Ershler W. Biological interactions of aging and anemia: a focus on cytokines. J. Am. Geriatr. Soc.51 (Suppl.), 18–21 (2003).
  • Fried L, Tangen C, Walston J et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A. Biol. Sci. Med. Sci.56(3), M134–M135 (2001).
  • Leng S, Chaves P, Koenig K, Waltson J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J. Am. Geriatr. Soc.50(7), 1268–1271 (2002).
  • Chaves P, Semba R, Leng S et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: WHAS I and II. J. Gerontol. A. Biol. Sci. Med. Sci.60(6), 729–735 (2005).
  • Wilkinson T, Warren M. What is the prognosis of mild normocytic anemia in older people? Intern. Med. J.33(1–2), 14–17 (2003).
  • Fuller G. Falls in the elderly. Am. Fam. Physician61, 2159–2168 (2000).
  • Duh M, Levebvre P, Buteau S, Mody S, Woodman R. Anemia and risk of accidental falls/fractures (AF/F) in the elderly. Presented at: 2005 Annual Scientific Meeting of the American Geriatrics Society (AGS), Orlando, FL, USA, 11–15 May (2005).
  • Dharmarajan T, Norkus E. Mild anemia and the risk of falls in older adults from nursing homes and the community. J. Am. Med. Dir. Assoc.5(6), 395–400 (2004).
  • Cesari M, Pahor M, Lauretani F et al. Bone density and hemoglobin levels in older persons: results from the InCHIANTI study. Osteoporos. Int.16(6), 691–699 (2005).
  • Dharmarajan T, Adiga G, Norkus E. Vitamin B12 deficiency: recognizing subtle symptoms in older adults. Geriatrics58, 30–38 (2003).
  • Johnson M, Hawthorne N, Brackett W et al. Hyperthromocycteinemia and vitamin B-12 deficiency in elderly using title IIIc nutrition services. Am. J. Clin. Nutr.77, 211–220 (2003).
  • Balducci L, Hardy C, Lyman G. Hematopoietic growth factors in the older cancer patient. Curr. Opin. Hematol.8, 170–178 (2001).
  • Cohen H, Harris T, Pieper C. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am. J. Med.114, 180–187 (2003).
  • Argyriadou S, Vlachonikolis I, Melisopoulou H et al. In what extent anemia coexists with cognitive impairment in elderly: a cross sectional study in Greece. BMC Fam. Pract.2, 5 (2001).
  • Atti A, Palmer K, Volpato S, Zuliani G, Winblad B, Fratiglioni L. Anaemia increases the risk of dementia in cognitively intact elderly. Neurobiol. Aging27(2), 278–284 (2006).
  • Whicker B, Cesari M, Pahor M et al. Anemia and cognition impairment in older persons: results from the “Invecchiare in Chianti” (Aging in the Chianti Area, InCHIANTI) Study. Presented at: 2005 Annual Scientific Meeting of the American Geriatrics Society (AGS), Orlando, FL, USA, 11–15 May (2005).
  • Zamboni V, Zuccala G, Cesari M et al. Relationship of hemoglobin levels and anemia with cognitive performance: results from the GIFA study. Presented at: 2005 Annual Scientific Meeting of the American Geriatrics Society (AGS), Orlando, FL, USA, 11–15 May (2005).
  • Chaves P, Siegartel L, Mody S, Woodman R. Anemia and associated comorbidities among the elderly. Blood104, B414 (2004) (Abstract 5315).
  • Chaves P, Xue Q, Guralnik J, Ferrucci L, Volpato S, Fried L. What constitutes normal hemoglobin concentration in community-dwelling disabled older women? J. Am. Geriatr. Soc.52(11), 1811–1816 (2004).
  • Izaks G, Westendorp R, Knook D. The definition of anemia in older persons. JAMA281, 1714–1717 (1999).
  • Herzog C, Muster H, Li S, Collins A. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J. Card. Fail.10(6), 467–472 (2004).
  • Penninx B, Pahor M, Woodman R, Ferrucci L, Guralnik J. Late-life anemia identifies persons at risk for mortality and hospitalization. Presented at: American Society of Consultant Pharmacists (ASCP) 35th Annual Meeting and Exhibition, San Francisco, CA, USA, 3–6 November (2004).
  • Nordyke R, Kim J, Goldberg G et al. Impact of anemia on hospitalization time, charges, and mortality in patients with heart failure. Value Health7(4), 464–467 (2004).
  • Chaves P, Mody S, Najib M, Siegartel L, Blasi M, Woodman R. Anemia in the elderly is associated with increased healthcare costs and resource utilization. Presented at: American Society of Hematology’s (ASH) 45th Annual Meeting, San Diego, CA, USA, 6–9 December (2003).
  • Duh M, Lefebvre P, Buteau S, Mody S, Bookhart B, McKenzie S. Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease (pCKD). Presented at: American Society of Nephrology (ASN) 38th Annual Renal Week Meeting, Philadelphia, PA, USA, 8–13 November (2005).
  • Cascinu S, Del Ferro E, Fedeli A, Ligi M, Alessandroni P, Catalano G. Recombinant human erythropoietin treatment in elderly cancer patients with cosplatin-associated anemia. Oncology52(5), 442–446 (1995).
  • Fink J, Provenzano R, Woodman R, Hill K, Yektashenas B, Klausner M. Comparative analysis of efficacy and safety of once-weekly (QW) epoetin alfa in elderly (≥65) and non-elderly (<65) patients with anemia due to chronic kidney disease (CKD). Poster presented at: 2004 Annual Meeting of the American Geriatric Society (AGS), Las Vegas, NV, USA, 18–21 May (2004).
  • Fink J, Yektashenas B, Blasi MV, Klausner M, Woodman RC, Provenzano R. Treatment of CKD anemia in octogenerians: a comparison of epoetin alfa (EPO) in elderly (65–79; ≥80) and non-elderly (<65) patients. Blood104, B17 (2004) (Abstract 3724).
  • Nicholas J. A study of response of elderly patients with end-stage renal disease to epoetin alfa or beta. Drugs Aging21(3), 187–201 (2004).
  • Xue J, St Peter W, Ebben J, Everson S, Collins A. Anemia treatment in the pre-ESRD period and associated mortality in elder patients. Am. J. Kidney. Dis.40(6), 1153–1161 (2002).
  • Woodman R, Yektashenas B, Fu W, Klausner M, McClellan W. Anemia in two groups of elderly (65–79 and ≥ 80) patients with chronic kidney disease (CKD). Blood104, B15 (2004) (Abstract 3719).

Websites

  • Procrit (epoetin alfa) prescribing information www.procrit.com/
  • Goodnough T et al. Anemia. A hidden epidemic. National Anemic Action Council report (2002) www.anemia.org.
  • National vital statistics reports www.cdc.gov/nchs/data/nvsr/nvsr52/nvsr52_21.pdf (Accessed 5/04/05)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.